SOPH · SOPHiA GENETICS SA
$6.05
-0.35 (-5.47%)
At close · Jul 23
Market Cap
$507.57M
Shares
83.90M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.05
Open$6.47
Day$6.03–6.52
52W$2.92–6.77
Avg vol 30d362K
Short int636K · 0.8% float · 1.4d
Short vol36%
Last earningsAug 4, 2026
DataJul 2021–Jul 2026
Up next
Next earnings call
Aug 4, 2026
Scheduled
· in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+23%
above
Price vs 50-day avg
+14%
above
RSI (14)
58
neutral
MACD trend
Positive
52-week position
81%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+10%
trailing
6-month return
+17%
trailing
YTD return
+30%
this year
Relative strength
+11%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
6 of 50 funds reported for Jun 30 · net +76.7K sh shares · +2 new
Insider flow
Distributing
Net -$150.0K over 90 days · 89% sells
Short interest
Rising
0.76% of float · ▲ +141.3% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
50 holders — near 3-yr high, broad support
Squeeze score
68
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
66%
annualized · 1-yr
Max drawdown
−26%
past year
ATR
6.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Sep 30, 2025
Revenue
· 2025
Initiated
$75M – $77M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+23%
Bullish
Price vs 50-day avg
+14%
Bullish
RSI (14)
58
Neutral
MACD trend
Positive
Bullish
52-week position
81%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
6 of 50 funds reported for Jun 30 · net +76.7K sh shares · +2 new
Insider flow
Distributing
Net -$150.0K over 90 days · 89% sells
Short interest
Rising
0.76% of float · ▲ +141.3% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
50 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $3
Now $6 · 81%
52-wk high $7
vs 200-day avg +23%
vs 50-day avg +14%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SOPH
this stock
SOPHiA GENETICS SA
|
$507.57M | +29.6% | — | — | 0.8% |
|
VEEV
Veeva Systems Inc
|
$29.17B | -19.6% | +28.1% | 31.8 | 4.6% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$15.41B | -10.9% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$13.54B | +86.5% | -0.4% | 49.9 | 6.6% |
|
TEM
Tempus AI, Inc.
|
$8.43B | -20.5% | +65.8% | — | 18.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SOPH | +3.8% | +9.6% | +17.0% | +4.9% | +29.6% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | +5.4% | +8.9% | +10.7% | +6.0% | +21.3% |